HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scot Ebbinghaus Selected Research

interleukin-4-Pseudomonas exotoxin

7/2005Phase I trial of intravenous IL-4 pseudomonas exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scot Ebbinghaus Research Topics

Disease

19Melanoma (Melanoma, Malignant)
01/2020 - 11/2005
15Neoplasms (Cancer)
01/2020 - 07/2005
6Disease Progression
01/2018 - 01/2015
3Stomatitis
01/2017 - 07/2013
3Pneumonia (Pneumonitis)
01/2017 - 07/2013
3Fatigue
08/2015 - 11/2005
2Brain Neoplasms (Brain Tumor)
10/2017 - 01/2017
2Autoimmune Diseases (Autoimmune Disease)
10/2017 - 01/2017
2Neutropenia
08/2015 - 11/2005
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 07/2005
1Lymphoma (Lymphomas)
01/2020
1Hodgkin Disease (Hodgkin's Disease)
01/2020
1Neuroblastoma
01/2020
1Microsatellite Instability
01/2020
1Neoplasm Metastasis (Metastasis)
10/2018
1Breast Neoplasms (Breast Cancer)
01/2017
1Myalgia
08/2015
1Colitis
08/2015
1Hyponatremia
08/2015
1Hypopituitarism (Sheehan's Syndrome)
08/2015
1Body Weight (Weight, Body)
06/2015
1Asthenia
01/2015
1Sarcoma (Soft Tissue Sarcoma)
07/2013
1Hyperglycemia
07/2013
1Thrombocytopenia (Thrombopenia)
07/2013
1Exanthema (Rash)
07/2013
1Infections
07/2013
1Liver Diseases (Liver Disease)
06/2010
1Renal Cell Carcinoma (Grawitz Tumor)
11/2007
1Nausea
11/2005
1Peripheral Nervous System Diseases (PNS Diseases)
11/2005
1Edema (Dropsy)
11/2005
1Ileus
11/2005
1Alopecia (Baldness)
11/2005
1Glioblastoma (Glioblastoma Multiforme)
07/2005

Drug/Important Bio-Agent (IBA)

17pembrolizumabIBA
01/2020 - 01/2015
11IpilimumabIBA
10/2018 - 01/2015
4B7-H1 AntigenIBA
10/2018 - 12/2016
4ridaforolimusIBA
01/2017 - 10/2012
3Immune Checkpoint InhibitorsIBA
01/2017 - 01/2015
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2017 - 08/2015
2SteroidsIBA
10/2017 - 01/2017
2dalotuzumabIBA
01/2017 - 01/2015
2TOR Serine-Threonine KinasesIBA
07/2013 - 10/2012
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2018
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2017
1exemestane (Aromasin)FDA Link
01/2017
1Aromatase InhibitorsIBA
01/2017
1Estrogen ReceptorsIBA
01/2017
1Monoclonal AntibodiesIBA
04/2016
1LigandsIBA
01/2015
1PlatinumIBA
01/2015
1Death Domain ReceptorsIBA
01/2015
1EnzymesIBA
06/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2008
1NAc- Sar- Gly- Val- (d- allo- Ile)- Thr- Nva- Ile- Arg- ProNEt (ABT 510)IBA
11/2007
1tasidotinIBA
11/2005
1Aspartic Acid (Aspartate)FDA Link
11/2005
1Transaminases (Aminotransferases)IBA
11/2005
1Alanine Transaminase (SGPT)IBA
11/2005
1Proteins (Proteins, Gene)FDA Link
07/2005
1ExotoxinsIBA
07/2005
1interleukin-4-Pseudomonas exotoxinIBA
07/2005
1Immunotoxins (Immunotoxin)IBA
07/2005
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
07/2005
1Interleukin-4 (Interleukin 4)IBA
07/2005

Therapy/Procedure

6Drug Therapy (Chemotherapy)
11/2017 - 07/2013
5Therapeutics
01/2018 - 06/2010
1Immunotherapy
01/2019